secwatch.observer — SEC 8-K summary
======================================

Issuer:     CARDINAL HEALTH INC (CAH)
CIK:        0000721371
Form:       8-K
Filed at:   2024-04-23T23:59:59+00:00
Accession:  0000721371-24-000030
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardinal Health recasts segment results under new structure for FY2022-H1 FY2024
--------------------------------------------------------------------------------

- New segments: Pharmaceutical & Specialty Solutions and Global Medical Products & Distribution; three smaller ops reported as Other.
- Recast unaudited quarterly data for FY2022, FY2023, and H1 FY2024; no change to consolidated revenue or net income.
- Pharm & Spec Solutions segment profit grew 13% in FY2023 to $1,862M; H1 FY2024 profit $961M.
- Global Medical Products & Distribution segment losses: FY2022 loss $49M, FY2023 loss $162M, H1 FY2024 loss $2M.
- Total segment revenue grew 13% in FY2023 to $205.1B; H1 FY2024 up 11% to $112.2B.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/721371/000072137124000030/0000721371-24-000030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/721371/000072137124000030/cah-20240423.htm
  HTML page:      https://secwatch.observer/filing/0000721371-24-000030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer